XML 60 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Ordinary shares
Additional paid in capital
Accumulated deficit
Accumulated other comprehensive income (loss)
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2020   878,110,260        
Beginning balance at Dec. 31, 2020 $ 1,169,345 $ 5 $ 1,897,467 $ (713,603) $ (14,524)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of ordinary shares upon vesting of restricted shares (in shares)   2,054,500        
Issuance of ordinary shares upon vesting of restricted shares 0 $ 0 0      
Exercise of shares options (in shares)   12,353,400        
Exercise of share options 7,417 $ 0 7,417      
Issuance of ordinary shares upon follow-on public offering, net of issuance cost (in shares)   57,164,000        
Issuance of ordinary shares upon follow-on public offering, net of issuance cost 818,036 $ 1 818,035      
Issuance of ordinary shares in connection with collaboration and license arrangement (Note 16) (in shares)   5,681,820        
Issuance of ordinary shares in connection with collaboration and license arrangement (Note 16) 62,250 $ 0 62,250      
Issuance cost adjustment for secondary listing 65   65      
Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation (in shares)           (382,930)
Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation (4,279)         $ (4,279)
Share-based compensation 40,714   40,714      
Net loss (704,471)     (704,471)    
Foreign currency translation (9,121)       (9,121)  
Ending balance (in shares) at Dec. 31, 2021   955,363,980        
Ending balance at Dec. 31, 2021 1,379,956 $ 6 2,825,948 (1,418,074) (23,645) $ (4,279)
Ending balance (in shares) at Dec. 31, 2021           (382,930)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of ordinary shares upon vesting of restricted shares (in shares)   1,940,680        
Issuance of ordinary shares upon vesting of restricted shares 0 $ 0 0      
Exercise of shares options (in shares)   5,151,190        
Exercise of share options 5,870 $ 0 5,870      
Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation (in shares)           (1,853,350)
Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation (7,577)         $ (7,577)
Share-based compensation 61,302   61,302      
Net loss (443,286)     (443,286)    
Foreign currency translation $ 49,330       49,330  
Ending balance (in shares) at Dec. 31, 2022 960,219,570 962,455,850        
Ending balance at Dec. 31, 2022 $ 1,045,595 $ 6 2,893,120 (1,861,360) 25,685 $ (11,856)
Ending balance (in shares) at Dec. 31, 2022 (2,236,280)         (2,236,280)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of ordinary shares upon vesting of restricted shares (in shares)   8,178,500        
Issuance of ordinary shares upon vesting of restricted shares $ 0 $ 0 0      
Exercise of shares options (in shares) 6,516,920 6,516,920        
Exercise of share options $ 2,548 $ 0 2,548      
Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation (in shares)           (2,675,920)
Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation (8,980)         $ (8,980)
Share-based compensation 79,634   79,634      
Net loss (334,620)     (334,620)    
Foreign currency translation $ 11,941       11,941  
Ending balance (in shares) at Dec. 31, 2023 972,239,070 977,151,270        
Ending balance at Dec. 31, 2023 $ 796,118 $ 6 $ 2,975,302 $ (2,195,980) $ 37,626 $ (20,836)
Ending balance (in shares) at Dec. 31, 2023 (4,912,200)         (4,912,200)